Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Unusual Presentation of a Breast Lump.
Pai N, Amonkar A, Ballal R. Pai N, et al. Indian J Surg. 2017 Jun;79(3):256-258. doi: 10.1007/s12262-016-1547-1. Epub 2016 Aug 19. Indian J Surg. 2017. PMID: 28659681 Free PMC article.
Primary Neuroendocrine Carcinoma of Breast.
Banu KJ, Ballal C R, Pai N, Permi H. Banu KJ, et al. Among authors: pai n. Indian J Surg Oncol. 2015 Jun;6(2):110-2. doi: 10.1007/s13193-014-0370-z. Epub 2015 Jan 25. Indian J Surg Oncol. 2015. PMID: 26405415 Free PMC article.
The Ætiology of Blackwater Fever.
Krishnan KV, Pai NG. Krishnan KV, et al. Among authors: pai ng. Ind Med Gaz. 1936 Mar;71(3):121-127. Ind Med Gaz. 1936. PMID: 29012965 Free PMC article. No abstract available.
Response from the Canadian Children Inflammatory Bowel Disease Network to the US Food and Drug Administration Draft Guidance for Industry on pediatric inflammatory bowel disease: developing drugs for treatment.
Wine E, deBruyn J, Crowley E, Griffiths AM; Canadian Children IBD Network. Wine E, et al. J Can Assoc Gastroenterol. 2024 Oct 12;7(6):397-398. doi: 10.1093/jcag/gwae034. eCollection 2024 Dec. J Can Assoc Gastroenterol. 2024. PMID: 39679099 Free PMC article. No abstract available.
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
295 results